NCT03834571 2022-06-21
Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive Women
AIDS Malignancy Consortium
Phase 2 Withdrawn
Clinical Trials
10 trialsNCT04806945 2022-05-05
A Phase III Study to Evaluate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy in Patients With Advanced Cervical Cancer
Shanghai Henlius Biotech
Phase 3 Withdrawn
NCT01019278 2020-04-03
Proton Beam Radiation Therapy and Cisplatin in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer and Positive Lymph Nodes
Abramson Cancer Center at Penn Medicine
Phase 2 Withdrawn
NCT00257829 2018-12-03
Improving Tumor Oxygenation in Cervical Cancer
University of California, Irvine
Phase 2 Withdrawn
NCT00428194 2017-11-29
Erlotinib, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB-Stage IVA Cervical Cancer
Masonic Cancer Center, University of Minnesota
Phase 1 Withdrawn
NCT01138137 2017-04-21
N-acetylcysteine Given IV With Cisplatin and Paclitaxel in Patients With Ovarian Cancer
OHSU Knight Cancer Institute
Phase 1 Withdrawn
NCT00967928 2014-02-14
Everolimus Dose Finding Study for Stage IV or Recurrent Cervical Cancer
Accelerated Community Oncology Research Network
Phase 1 Withdrawn
NCT00942838 2013-07-24
WAR
University of Utah
Phase 1 Withdrawn
NCT00137358 2013-01-24
Radiation With Chemotherapy and a Study Drug to the Para-Aortic Nodes in Cervical Cancer
University of Alabama at Birmingham
Phase 1 Withdrawn
NCT00057928 2012-06-13
S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical Cancer
SWOG Cancer Research Network
Phase 3 Withdrawn